Study Summary
This trial will assess whether red light can help treat vitiligo, a chronic skin disease.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: assessments at 2, 4, 6, 8 and 10 weeks during treatment then at 4, 8, and 12 weeks post treatment
Week 12
Change in the modified VASI score compared to baseline.
Trial Safety
Safety Progress
This is further along than 68% of similar trials
Trial Design
4 Treatment Groups
High intensity red light
1 of 4
No treatment1 (covered)
1 of 4
Low intensity red laser
1 of 4
No treatment2 (covered)
1 of 4
Active Control
16 Total Participants · 4 Treatment Groups
Primary Treatment: High intensity red light · No Placebo Group · Phase 2
High intensity red light
Procedure
ActiveComparator Group · 1 Intervention: Red light · Intervention Types: ProcedureNo treatment1 (covered)NoIntervention Group · 1 Intervention: No treatment1 (covered) · Intervention Types:
Low intensity red laser
Procedure
ActiveComparator Group · 1 Intervention: Red light · Intervention Types: ProcedureNo treatment2 (covered)NoIntervention Group · 1 Intervention: No treatment2 (covered) · Intervention Types:
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: assessments at 2, 4, 6, 8 and 10 weeks during treatment then at 4, 8, and 12 weeks post treatment
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,325 Previous Clinical Trials
1,534,077 Total Patients Enrolled
4 Trials studying Vitiligo
109 Patients Enrolled for Vitiligo
Harvey Lui, MD, FRCPCPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
64 Total Patients Enrolled
3 Trials studying Vitiligo
64 Patients Enrolled for Vitiligo
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You have localized or generalized vitiligo that involves a non mucosal or acral site.
Patients should have a patch of at least 25 cm2 that shows no more than 10% repigmentation as assessed visually.
Who else is applying?
How old are they?
| 18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 100.0% |
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments